Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis

English version České info

The mouse polyoma virus induces a broad array of solid tumors in mice of many inbred strains. In most strains tumors grow rapidly but fail to metastasize. An exception has been found in the Czech-II/Ei mouse in which bone tumors metastasize regularly to the lung. These tumors resemble human osteosarcoma in their propensity for pulmonary metastasis. Cell lines established from these metastatic tumors have been compared with ones from non-metastatic osteosarcomas arising in C3H/BiDa mice. Osteopontin, a chemokine implicated in migration and metastasis, is known to be transcriptionally induced by the viral middle T antigen. Czech-II/Ei and C3H/BiDa tumor cells expressed middle T and secreted osteopontin at comparable levels as the major chemoattractant. The tumor cell lines migrated equally well in response to recombinant osteopontin as the sole attractant. An important difference emerged in assays for invasion in which tumor cells from Czech-II/Ei mice were able to invade across an extracellular matrix barrier while those from C3H/BiDa mice were unable to invade. Invasive behavior was linked to elevated levels of the metalloproteinase MMP-2 and of the transcription factor NFAT. Inhibition of either MMP-2 or NFAT inhibited invasion by Czech-II/Ei osteosarcoma cells. The metastatic phenotype is dominant in F1 mice. Osteosarcoma cell lines from F1 mice expressed intermediate levels of MMP-2 and NFAT and were invasive. Osteosarcomas in Czech-II/Ei mice retain functional p53. This virus-host model of metastasis differs from engineered models targeting p53 or pRb and provides a system for investigating the genetic and molecular basis of bone tumor metastasis in the absence of p53 loss.

Vyšlo v časopise: Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000733
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000733

Souhrn

Zdroje

1. MolloyT

van 't VeerLJ

2008 Recent advances in metastasis research. Curr Opin Genet Dev 18 35 41

2. CardiffRD

MunnRJ

GalvezJJ

2007 Chapter 24. The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology. 581 622 In The Mouse in Biomedical Research, 2nd Edition JJ Fox, MT Davisson, FW Quimby, AW Barthold, CE Newcomer, AL Smith, editors Academic Press:

3. BilgerA

ShoemakerAR

GouldKA

DoveWF

1996 Manipulation of the mouse germline in the study of Min-induced neoplasia. Semin Cancer Biol 7 249 260

4. DietrichWF

LanderES

SmithJS

MoserAR

GouldKA

1993 Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75 631 639

5. BalmainA

NagaseH

1998 Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet 14 139 144

6. BenjaminTL

2007 Chapter 5. Polyoma Viruses. 105 139 In The Mouse in Biomedical Research, 2nd Edition JJ Fox, MT Davisson, FW Quimby, AW Barthold, CE Newcomer, AL Smith, editors Academic Press:

7. TsaiB

GilbertJM

StehleT

LencerW

BenjaminTL

2003 Gangliosides are receptors for murine polyoma virus and SV40. Embo J 22 4346 4355

8. CarrollJ

DeyD

KreismanL

VelupillaiP

DahlJ

2007 Receptor-binding and oncogenic properties of polyoma viruses isolated from feral mice. PLoS Pathog 3 e179 doi:10.1371/journal.ppat.0030179

9. BauerPH

BronsonRT

FungSC

FreundR

StehleT

1995 Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J Virol 69 7925 7931

10. BronsonR

DaweC

CarrollJ

BenjaminT

1997 Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc Natl Acad Sci U S A 94 7954 7958

11. FreundR

BronsonRT

BenjaminTL

1992 Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene 7 1979 1987

12. FreundR

CalderoneA

DaweCJ

BenjaminTL

1991 Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J Virol 65 335 341

13. FreundR

DaweCJ

CarrollJP

BenjaminTL

1992 Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol 141 1409 1425

14. DaweCJ

FreundR

MandelG

Ballmer-HoferK

TalmageDA

1987 Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol 127 243 261

15. SchaffhausenBS

RobertsTM

2009 Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer. Virology 384 304 316

16. GuyCT

CardiffRD

MullerWJ

1992 Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12 954 961

17. JessenKA

LiuSY

TepperCG

KarrimJ

McGoldrickET

2004 Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res 6 R157 169

18. VelupillaiP

YoshizawaI

DeyDC

NahillSR

CarrollJP

1999 Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors. J Virol 73 10079 10085

19. Uribe-BoteroG

RussellWO

SutowWW

MartinRG

1977 Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54. Am J Clin Pathol 67 427 435

20. LukacherAE

MaY

CarrollJP

Abromson-LeemanSR

LaningJC

1995 Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181 1683 1692

21. WhalenKA

WeberGF

BenjaminTL

SchaffhausenBS

2008 Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J Virol 82 4946 4954

22. AlbiniA

1998 Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 4 230 241

23. LoukopoulosP

O'BrienT

GhoddusiM

MungallBA

RobinsonWF

2004 Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res Vet Sci 77 131 141

24. RaoA

LuoC

HoganPG

1997 Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15 707 747

25. Alfonso-JaumeMA

MahimkarR

LovettDH

2004 Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. Biochem J 380 735 747

26. JauliacS

Lopez-RodriguezC

ShawLM

BrownLF

RaoA

2002 The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4 540 544

27. PanS

Koyano-NakagawaN

TsurutaL

AmasakiY

YokotaT

1997 Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc. Biochem Biophys Res Commun 240 314 323

28. ShermanMA

PowellDR

WeissDL

BrownMA

1999 NF-ATc isoforms are differentially expressed and regulated in murine T and mast cells. J Immunol 162 2820 2828

29. LuoC

BurgeonE

CarewJA

McCaffreyPG

BadalianTM

1996 Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol 16 3955 3966

30. ChenL

GloverJN

HoganPG

RaoA

HarrisonSC

1998 Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392 42 48

31. RiesC

EgeaV

KarowM

KolbH

JochumM

2007 MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109 4055 4063

32. VisseR

NagaseH

2003 Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 827 839

33. JacksT

RemingtonL

WilliamsBO

SchmittEM

HalachmiS

1994 Tumor spectrum analysis in p53-mutant mice. Curr Biol 4 1 7

34. LangGA

IwakumaT

SuhYA

LiuG

RaoVA

2004 Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119 861 872

35. OliveKP

TuvesonDA

RuheZC

YinB

WillisNA

2004 Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119 847 860

36. WalkleyCR

QudsiR

SankaranVG

PerryJA

GostissaM

2008 Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 22 1662 1676

37. BermanSD

CaloE

LandmanAS

DanielianPS

MillerES

2008 Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A 105 11851 11856

38. GokgozN

WunderJS

MoussesS

EskandarianS

BellRS

2001 Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 92 2181 2189

39. DeyDC

BronsonRP

DahlJ

CarrollJP

BenjaminTL

2000 Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds. Cell Growth Differ 11 231 237

40. DahlJ

YouJ

BenjaminTL

2005 Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol 79 13007 13017

41. LaroseA

DysonN

SullivanM

HarlowE

BastinM

1991 Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J Virol 65 2308 2313

42. GiannelliG

AstigianoS

AntonaciS

MoriniM

BarbieriO

2002 Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis 19 217 223

43. WangDR

SatoM

LiLN

MiuraM

KojimaN

2003 Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells. Cell Struct Funct 28 505 513